J. Northover, R. Glynne-jones, D. Sebag-montefiore, J. R. Meadows, H. Wan et al.,

, Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), Br J Cancer, vol.102, issue.7, pp.1123-1131, 2010.

H. Bartelink, F. Roelofsen, F. Eschwege, P. Rougier, J. F. Bosset et al., Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, J Clin Oncol, vol.15, issue.5, pp.2040-2049, 1997.

M. Flam, M. John, T. F. Pajak, N. Petrelli, R. Myerson et al., Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, vol.14, issue.9, pp.2527-2566, 1996.

L. L. Gunderson, K. A. Winter, J. A. Ajani, J. E. Pedersen, J. Moughan et al., Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin, J Clin Oncol, vol.30, issue.35, pp.4344-51, 2012.

R. D. James, R. Glynne-jones, H. M. Meadows, D. Cunningham, A. S. Myint et al.,

, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2$\times$ 2 factorial trial, Lancet Oncol, vol.14, issue.6, pp.516-540, 2013.

P. Das, S. Bhatia, C. Eng, J. A. Ajani, J. M. Skibber et al., Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer, Int J Radiat Oncol, vol.68, issue.3, pp.794-800, 2007.

J. L. Wright, S. M. Patil, L. Temple, B. D. Minsky, L. B. Saltz et al., Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for Intensity-Modulated Radiation Treatment Planning, Int J Radiat Oncol, vol.78, issue.4, pp.1064-72, 2010.

S. Vieillot, P. Fenoglietto, C. Lemanski, C. L. Moscardo, S. Gourgou et al., IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center, Radiat Oncol, vol.7, issue.1, p.45, 2012.

V. Vendrely, B. Henriques-de-figueiredo, E. Rio, J. Benech, S. Belhomme et al., French multicentre clinical evaluation of helical TomoTherapy® for anal cancer in a cohort of 64 consecutive patients, Radiat Oncol, vol.10, issue.1, 2015.

C. J. Brooks, Y. K. Lee, K. Aitken, V. N. Hansen, D. M. Tait et al., Organ-sparing Intensitymodulated Radiotherapy for Anal Cancer using the ACTII Schedule: A Comparison of Conventional and Intensity-modulated Radiotherapy Plans, Clin Oncol, vol.25, issue.3, pp.155-61, 2013.

L. A. Kachnic, K. Winter, R. J. Myerson, M. D. Goodyear, J. Willins et al., RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal, Int J Radiat Oncol, vol.86, issue.1, pp.27-33, 2013.

M. T. Milano, A. B. Jani, K. J. Farrey, C. Rash, R. Heimann et al., Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome, Int J Radiat Oncol, vol.63, issue.2, pp.354-61, 2005.

Y. Chen, A. Liu, P. T. Tsai, N. L. Vora, R. D. Pezner et al., Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes, Int J Radiat Oncol, vol.63, issue.1, pp.274-81, 2005.

M. D. Chuong, J. M. Freilich, S. E. Hoffe, . Fulp, . William et al., Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal, Gastrointest Cancer Res, vol.6, pp.39-45, 2013.

D. M. Cannon, N. Lee, A. Eisbruch, L. H. Marsh, L. A. Dawson et al., Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing, Int J Radiat Oncol, vol.70, issue.3, pp.28-42, 2004.

M. Ng, T. Leong, S. Chander, J. Chu, A. Kneebone et al., Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal Cancer, Int J Radiat Oncol, vol.83, issue.5, pp.1455-62, 2012.

R. J. Myerson, M. C. Garofalo, E. Naqa, I. Abrams, R. A. Apte et al., Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas, Int J Radiat Oncol, vol.74, issue.3, pp.824-854, 2009.

D. Azria, Site Internat de radioanatomie et d'autoenseignement à la délinéation (SIRIADE). Paris: Afcor,SFRO,SFJRO, 2011.

J. Ajani, K. Winter, L. Gunderson, J. Pedersen, A. B. Benson et al., Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal, JAMA, vol.299, issue.16, pp.1914-1935, 2008.

D. Peiffert, L. Tournier-rangeard, J. Gérard, C. Lemanski, E. François et al.,

, Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial, J Clin Oncol, vol.30, issue.16, pp.1941-1949, 2012.

S. Ramamoorthy, L. Luo, E. Luo, and J. M. Carethers, Tobacco smoking and risk of recurrence for squamous cell cancer of the anus, Cancer Detect Prev, vol.32, issue.2, pp.116-136, 2008.

A. Cordoba, A. Escande, T. Leroy, X. Mirabel, B. Coche-dequ?ant et al., Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers, Brachytherapy, vol.16, issue.1, pp.230-235, 2017.

H. Ortholan, C. Resbeut, M. Teissier, E. Ronchin, P. Cowen et al., High-Dose Split-Course Radiation Therapy for Anal Cancer: Outcome Analysis Regarding the Boost Strategy (CORS03 Study), Int J Radiat Oncol, vol.80, issue.3, pp.712-732, 2011.

B. De and L. A. Thèse,

L. G. Johnson, M. M. Madeleine, L. M. Newcomer, S. M. Schwartz, and J. R. Daling, Anal cancer incidence and survival: The Surveillance, Epidemiology, and End Results experience, Cancer, vol.101, issue.2, pp.281-289, 1973.

A. E. Grulich, I. M. Poynten, D. A. Machalek, J. F. Templeton, D. J. Hillman et al., The epidemiology of anal cancer, Sex Health, vol.9, issue.6, p.504, 2012.

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, 2017. CA Cancer J Clin, 2017.

A. Bouvier, A. Belot, S. Manfredi, V. Jooste, Z. Uhry et al., Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study, Eur J Cancer Prev, vol.25, issue.3, pp.182-189, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01442356

F. Islami, J. Ferlay, J. Lortet-tieulent, F. Bray, and A. Jemal, International trends in anal cancer incidence rates, Int J Epidemiol, p.276, 2016.

G. Nilsson, P. J. Aschele, C. Goh, V. Peiffert, D. Cervantes et al., Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis
URL : https://hal.archives-ouvertes.fr/hal-01799935

, Radiother Oncol, vol.111, issue.3, pp.330-339, 2014.

M. Fesneau, É. Champeaux-orange, and C. Hennequin, Cancer du canal anal

, Cancer/Radiothérapie, vol.14, pp.120-126, 2010.

S. Grabar, D. Costagliola, and A. Bouvier, Épidémiologie du cancer de l'anus. Cancéro Dig, 2011.

L. A. Aaltonen and S. R. Hamilton, World Health Organization, International Agency for Research on Cancer, Pathology and genetics of tumours of the digestive system. Lyon : Oxford: IARC Press

M. Frisch, On the etiology of anal squamous carcinoma, Dan Med Bull, 2002.

J. Fléjou, Classification OMS 2010 des tumeurs digestives : la quatrième édition, Ann Pathol, vol.31, issue.5, pp.27-31, 2011.

J. Palmer, J. Scholefield, P. Coates, N. Shepherd, J. Jass et al., Anal cancer and human papillomaviruses, Dis Colon Rectum, vol.32, issue.12, pp.1016-1038, 1989.

N. Muñoz, F. X. Bosch, S. De-sanjosé, R. Herrero, X. Castellsagué et al.,

, Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer, N Engl J Med, vol.348, issue.6, pp.518-545, 2003.

L. Abramowitz, A. Jacquard, F. Jaroud, J. Haesebaert, L. Siproudhis et al., Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study, Int J Cancer, vol.129, issue.2, pp.433-442, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00563122

A. E. Grulich, M. T. Van-leeuwen, M. O. Falster, and C. M. Vajdic, Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. The Lancet, vol.370, pp.59-67, 2007.

J. R. Daling, M. M. Madeleine, L. G. Johnson, S. M. Schwartz, K. A. Shera et al., Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer, vol.101, pp.270-80, 2004.

J. R. Daling, K. J. Sherman, T. G. Hislop, C. Maden, M. T. Mandelson et al., Cigarette smoking and the risk of anogenital cancer, Am J Epidemiol, vol.135, issue.2, pp.180-189, 1992.

A. Slesser, A. Bhangu, M. Bower, R. Goldin, and P. P. Tekkis, A systematic review of anal squamous cell carcinoma in inflammatory bowel disease, Surg Oncol, vol.22, issue.4, pp.230-237, 2013.

P. Bannas, C. Weber, G. Adam, T. Frenzel, T. Derlin et al.,

, Emission Tomography/Computed Tomography for Staging and Radiotherapy Planning in Patients With Anal Cancer, Int J Radiat Oncol, vol.81, issue.2, pp.445-51, 2011.

S. S. Saboo, K. Zukotynski, A. B. Shinagare, K. M. Krajewski, and N. Ramaiya, Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up, Abdom Imaging, vol.38, issue.4, pp.728-763, 2013.

S. E. Cotter, P. W. Grigsby, B. A. Siegel, F. Dehdashti, R. S. Malyapa et al., FDGPET/CT in the evaluation of anal carcinoma, Int J Radiat Oncol, vol.65, issue.3, pp.720-725, 2006.

L. Vercellino, F. Montravers, V. De-parades, V. Huchet, K. Kerrou et al., Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma, Int J Colorectal Dis, vol.26, issue.2, pp.201-211, 2011.

. Winton-e-de, A. G. Heriot, M. Ng, R. J. Hicks, A. Hogg et al., The impact of 18fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer, Br J Cancer, vol.100, issue.5, pp.693-700, 2009.

J. Northover, R. Glynne-jones, D. Sebag-montefiore, J. R. Meadows, H. Wan et al.,

, Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I), Br J Cancer, vol.102, issue.7, pp.1123-1131, 2010.

P. Das, S. Bhatia, C. Eng, J. A. Ajani, J. M. Skibber et al., Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal Cancer, Int J Radiat Oncol, vol.68, issue.3, pp.794-800, 2007.

J. L. Wright, S. M. Patil, L. Temple, B. D. Minsky, L. B. Saltz et al., Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for IntensityModulated Radiation Treatment Planning, Int J Radiat Oncol, vol.78, issue.4, pp.1064-72, 2010.

M. P. Pintor, J. M. Northover, and R. J. Nicholls, Squamous cell carcinoma of the anus at one hospital from 1948 to 1984, Br J Surg, vol.76, issue.8, pp.806-816, 1989.

B. Cummings, T. Keane, G. Thomas, A. Harwood, and W. Rider, Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer, vol.54, pp.2062-2070, 1984.

J. Papillon, M. Mayer, J. F. Montbarbon, J. P. Gerard, J. L. Chassard et al., A new approach to the management of epidermoid carcinoma of the anal canal. Cancer, vol.51, pp.1830-1837, 1983.

F. Eschwege, P. Lasser, A. Chavy, P. Wibault, J. Kac et al., Squamous cell carcinoma of the anal canal: treatment by external beam irradiation, Radiother Oncol, vol.3, issue.2, pp.145-50, 1985.

E. Touboul, M. Schlienger, L. Buffat, D. Lefkopoulos, F. Pène et al., Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients, Cancer, vol.73, issue.6, pp.1569-79, 1994.

H. Bartelink, F. Roelofsen, F. Eschwege, P. Rougier, J. F. Bosset et al.,

, Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, J Clin Oncol, vol.15, issue.5, pp.2040-2049, 1997.

M. Flam, M. John, T. F. Pajak, N. Petrelli, R. Myerson et al., Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, vol.14, issue.9, pp.2527-2566, 1996.

L. L. Gunderson, K. A. Winter, J. A. Ajani, J. E. Pedersen, J. Moughan et al., LongTerm Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin, J Clin Oncol, vol.30, issue.35, pp.4344-51, 2012.

R. D. James, R. Glynne-jones, H. M. Meadows, D. Cunningham, A. S. Myint et al.,

, Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2$\times$ 2 factorial trial, Lancet Oncol, vol.14, issue.6, pp.516-540, 2013.

D. Peiffert, L. Tournier-rangeard, J. Gérard, C. Lemanski, E. François et al., Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial, J Clin Oncol, vol.30, issue.16, pp.1941-1949, 2012.

T. Conroy, M. Ducreux, C. Lemanski, E. Francois, M. Giovannini et al.,

, Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): Definitive analysis of the intergroup ACCORD 03 trial, J Clin Oncol, vol.27, issue.15S, p.4033, 2009.

W. Cacheux, A. Lievre, D. La-rochefordiere, A. Dieumegard, B. Cvitkovic et al.,

, Chemotherapy in the treatment of anal canal carcinoma. Dig Liver Dis, vol.44, pp.803-814, 2012.

J. Ajani, K. Winter, L. Gunderson, J. Pedersen, A. B. Benson et al., Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal, JAMA, vol.299, issue.16, pp.1914-1935, 2008.

F. F. De-cancérologie-digestive, Chapitre 6 Cancer du canal anal, 2017.

, Anon. NCCN clinical practice guidelines (NCCN Guidelines®) in oncology. Anal carcinoma. Fort Washington, PA: National Comprehensive Cancer Network, 2014.

M. Ng, T. Leong, S. Chander, J. Chu, A. Kneebone et al., Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for IntensityModulated Radiotherapy in Anal Cancer, Int J Radiat Oncol, vol.83, issue.5, pp.1455-62, 2012.

A. Konski, M. Garcia, M. John, R. Krieg, W. Pinover et al., Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08, Int J Radiat Oncol, vol.72, issue.1, pp.114-122, 2008.

M. T. Milano, A. B. Jani, K. J. Farrey, C. Rash, R. Heimann et al., Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome, Int J Radiat Oncol, vol.63, issue.2, pp.354-61, 2005.

Y. Chen, A. Liu, P. T. Tsai, N. L. Vora, R. D. Pezner et al., Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes, Int J Radiat Oncol, vol.63, issue.1, pp.274-81, 2005.

C. Menkarios, D. Azria, ?. Lalibert, C. Moscardo, S. Gourgou et al., Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans, Radiat Oncol, vol.2, issue.1, p.41, 2007.

L. A. Kachnic, K. Winter, R. J. Myerson, M. D. Goodyear, J. Willins et al., RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal, Int J Radiat Oncol, vol.86, issue.1, pp.27-33, 2013.

R. J. Myerson, M. C. Garofalo, E. Naqa, I. Abrams, R. A. Apte et al., Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas, Int J Radiat Oncol, vol.74, issue.3, pp.824-854, 2006.

D. Azria, D. Peiffert, G. Cr?hange, V. Vendrely, A. Baumann et al., Radioth?rapie des cancers du canal anal. Cancer/Radioth?rapie, Site Internat de radioanatomie et d'autoenseignement à la délinéation (SIRIADE), vol.20, pp.183-191, 2011.

L. A. Dawson, Y. Anzai, L. Marsh, M. K. Martel, A. Paulino et al., Patterns of localregional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer, Int J Radiat Oncol Biol Phys, vol.46, issue.5, pp.1117-1143, 2000.

D. M. Cannon, N. Lee, A. Eisbruch, L. H. Marsh, L. A. Dawson et al., Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing, Int J Radiat Oncol, vol.70, issue.3, pp.28-42, 2004.

S. Vieillot, P. Fenoglietto, C. Lemanski, C. L. Moscardo, S. Gourgou et al., IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center, Radiat Oncol, vol.7, issue.1, p.45, 2012.

V. Vendrely, B. Henriques-de-figueiredo, E. Rio, J. Benech, S. Belhomme et al., French multicentre clinical evaluation of helical TomoTherapy® for anal cancer in a cohort of 64 consecutive patients, Radiat Oncol, vol.10, issue.1, 2015.

C. J. Brooks, Y. K. Lee, K. Aitken, V. N. Hansen, D. M. Tait et al., Organ-sparing Intensity-modulated Radiotherapy for Anal Cancer using the ACTII Schedule: A Comparison of Conventional and Intensity-modulated Radiotherapy Plans, Clin Oncol, vol.25, issue.3, pp.155-61, 2013.

M. D. Chuong, J. M. Freilich, S. E. Hoffe, . Fulp, . William et al., Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal, Gastrointest Cancer Res, vol.6, pp.39-45, 2013.

S. Ramamoorthy, L. Luo, E. Luo, and J. M. Carethers, Tobacco smoking and risk of recurrence for squamous cell cancer of the anus, Cancer Detect Prev, vol.32, issue.2, pp.116-136, 2008.

A. Cordoba, A. Escande, T. Leroy, X. Mirabel, B. Coche-dequ?ant et al., Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers, Brachytherapy, vol.16, issue.1, pp.230-235, 2017.

H. Ortholan, C. Resbeut, M. Teissier, E. Ronchin, P. Cowen et al., HighDose Split-Course Radiation Therapy for Anal Cancer: Outcome Analysis Regarding the Boost Strategy (CORS-03 Study), Int J Radiat Oncol, vol.80, issue.3, pp.712-732, 2011.